Literature DB >> 25751645

Serum free light chain trends between orthotopic heart transplantation and auto-SCT in patients with AL amyloidosis.

A S Renteria1, V Sanchorawala1, E D Niehaus2, F Sun3, M J Semigran2, D C Seldin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25751645     DOI： 10.1038/bmt.2015.9

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.

Authors:  Lauren Gray Gilstrap; Emily Niehaus; Rajeev Malhotra; Van-Khue Ton; James Watts; David C Seldin; Joren C Madsen; Marc J Semigran
Journal:  J Heart Lung Transplant       Date:  2013-11-05       Impact factor: 10.247

2.  Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients.

Authors:  Maria Teresa Cibeira; Vaishali Sanchorawala; David C Seldin; Karen Quillen; John L Berk; Laura M Dember; Adam Segal; Frederick Ruberg; Hans Meier-Ewert; Nancy T Andrea; J Mark Sloan; Kathleen T Finn; Gheorghe Doros; Joan Blade; Martha Skinner
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

3.  A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.

Authors:  Ashutosh D Wechalekar; Stefan O Schonland; Efstathios Kastritis; Julian D Gillmore; Meletios A Dimopoulos; Thirusha Lane; Andrea Foli; Darren Foard; Paolo Milani; Lisa Rannigan; Ute Hegenbart; Philip N Hawkins; Giampaolo Merlini; Giovanni Palladini
Journal:  Blood       Date:  2013-03-11       Impact factor: 22.113

4.  Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies.

Authors:  Brandon C Varr; Michaela Liedtke; Sally Arai; Richard A Lafayette; Stanley L Schrier; Ronald M Witteles
Journal:  J Heart Lung Transplant       Date:  2011-11-03       Impact factor: 10.247

5.  Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.

Authors:  Bimalangshu R Dey; Stephen S Chung; Thomas R Spitzer; Hui Zheng; Thomas E Macgillivray; David C Seldin; Steven McAfee; Karen Ballen; Eyal Attar; Thomas Wang; Jordan Shin; Christopher Newton-Cheh; Stephanie Moore; Vaishali Sanchorawala; Martha Skinner; Joren C Madsen; Marc J Semigran
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

6.  Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.

Authors:  S Girnius; D C Seldin; H K Meier-Ewert; J M Sloan; K Quillen; F L Ruberg; J L Berk; G Doros; V Sanchorawala
Journal:  Bone Marrow Transplant       Date:  2013-12-09       Impact factor: 5.483

7.  Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey.

Authors:  J D Hosenpud; T DeMarco; O H Frazier; B P Griffith; B F Uretsky; A H Menkis; J B O'Connell; M T Olivari; H A Valantine
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

8.  Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis.

Authors:  Angela Dispenzieri; Morie A Gertz; Robert A Kyle; Martha Q Lacy; Mary F Burritt; Terry M Therneau; Philip R Greipp; Thomas E Witzig; John A Lust; S Vincent Rajkumar; Rafael Fonseca; Steven R Zeldenrust; Christopher G A McGregor; Allan S Jaffe
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

9.  Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.

Authors:  Martha Q Lacy; Angela Dispenzieri; Suzanne R Hayman; Shaji Kumar; Robert A Kyle; S Vincent Rajkumar; Brooks S Edwards; Richard J Rodeheffer; Robert P Frantz; Sudhir S Kushwaha; Alfredo L Clavell; Joseph A Dearani; Thoralf M Sundt; Richard C Daly; Christopher G A McGregor; Dennis A Gastineau; Mark R Litzow; Morie A Gertz
Journal:  J Heart Lung Transplant       Date:  2008-07-03       Impact factor: 10.247

10.  Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.

Authors:  Julian D Gillmore; Hugh J Goodman; Helen J Lachmann; Mark Offer; Ashutosh D Wechalekar; Jayshree Joshi; Mark B Pepys; Philip N Hawkins
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.